CHAPTER 6 Routine Follow-Up Appointments
Monitoring for PN complications—whether metabolic, mechanical, or infectious—is important because therapy may need to be temporarily interrupted to resolve these issues (see Chapter 5 for more on compli- cations associated with PN). For patients at home, routine outpatient clinic follow-up is necessary to physically examine the patient, complete a nutrition focused physical examination, evaluate functional status, assess for nutrient deficiencies or excesses, inspect the CVAD, and eval- uate the patient’s psychosocial status.26,29
These appointments can be
in-person or virtual, but it is important to note that there are limitations to virtual visits (eg, limited physical examination, concerns for bad video or audio connection).26
evaluated routinely by the facility’s clinicians but may still require regu- lar follow-up visits with specialists, including nutrition support provid- ers. Box 6.11 provides an example of a clinic follow-up schedule.
BOX 6.11 Example of Routine Clinic Follow-Up Schedule Time frame
Evaluation
1 month after start of therapy
Complete nutrition focused physical examination. Inspect the vascular access device.
Assess tolerance to therapy, functional status, and any concerns the patient has with home parenteral nutrition therapy.
Assess quality of life (QOL).
3 months after start of therapy
Every 6 months to 1 year
Same as above. Reassess nutrition goals. Assess QOL.
Same as above.
Evaluate and address any long-term complications of therapy (eg, metabolic bone disease, or parenteral nutrition–associated liver disease).
Assess QOL. Patients at alternate sites will be monitored and
110
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149